Korro Bio, Inc. 8-K Summary
Business Context and Reporting Period
This Form 8-K reports the results of the 2025 Annual Meeting of Stockholders held on June 11, 2025. Korro Bio, Inc. is a Delaware corporation with its principal executive offices in Cambridge, MA, and its common stock trades on The Nasdaq Capital Market under the symbol KRRO.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance matters and voting results.
Material Changes and Voting Results
Stockholders voted on four primary matters at the Annual Meeting:
- Director Elections: Ram Aiyar and Katharine Knobil were elected with overwhelming support (over 99% of votes cast). Jean-François Formela was elected but received significant opposition, with approximately 27.5% of votes cast withheld (3,011,490 votes withheld vs. 4,986,043 votes for).
- Executive Compensation: Stockholders approved the advisory vote on named executive officer compensation with 99.3% of votes cast in favor.
- Compensation Vote Frequency: Stockholders approved a 1-year frequency for future advisory votes on executive compensation.
- Auditor Ratification: Stockholders ratified the selection of Ernst & Young LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2025, with 99.8% of votes cast in favor.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for financial guidance, future outlook, management commentary on operations, or specific risk factors. The document is limited to the disclosure of voting outcomes.
Key Facts for Investor Verification
- Verify the reasons behind the significant vote withholding (approx. 27.5%) for director nominee Jean-François Formela compared to the other nominees.
- Confirm the total number of shares outstanding and the percentage of total shares represented by the broker non-votes (360,141 shares) to assess overall shareholder engagement.
- Review the company's subsequent 10-K or 10-Q filings for the financial metrics and operational updates not included in this 8-K.